Latest ArticlesTo compare the cost effectiveness of blinatumomab and chemotherapy in the treatment of relapsed or refractory precursor B-Cell acute lymphoblastic leukemia (ALL) from Chinese societal perspective.
A partition survival model with three health states (event-free, recurrence and death) was conducted over a 20 years horizon. Clinical data accessed from the phase Ⅲ randomized controlled clinical study 20120215, utility values were obtained from the quality of life study of leukemia patients in Shanghai Children's Medical Centre, and cost inputs were identified from the Eliancloud database, Menet database, National Bureau of Statistics etc. The threshold of willingness to pay (WTP) was CNY 128 547 (1.50 times of 2022 Chinese per capita GDP). Deterministic sensitivity analysis and probabilistic sensitivity analysis were conducted to access the robustness of model and findings.
The patients of intervention group achieved 8.74 quality-adjusted life years (QALYs) and 10.53 life years (LYs), compared with control group, an increase of 3.01 QALYs and 3.46 LYs. The total cost for intervention group was CNY 1 060 929, an increase of CNY 245 719 compared with control group. The incremental cost effectiveness ratio (ICER) in intervention group compared with control group was CNY 81 623 per QALY. Results were robust to sensitivity analyses.
Blinatumomab is more cost effective in pediatric patients with relapsed or refractory precursor B-Cell ALL compared with chemotherapy from Chinese societal perspective.
To observe the efficacy of compound Yinqiaojiedu mixture combined with acupuncture in treating moderate acne heat-toxin syndrome.
Patients with moderate acne heat-toxin syndrome were randomly divided into treatment group and control group, 30 cases in each group. The treatment group was treated with compound Yinqiaojiedu mixture (twice a day, 30 mL each time) combined with acupuncture clearance (once a week), and the control group was treated with minocycline hydrochloride (twice a day, 50 mg each time). The skin lesion count, traditional Chinese medicine (TCM) syndrome score, dermatology life quality index (DLQI) and inflammatory cytokines in peripheral blood, including interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α were compared between the two groups.
The total effective rate was 90.00% in the treatment group and 93.33% in the control group, and there was no significant difference in the total effective rate between the two groups (P>0.05). The total effective rate of the two groups in the treatment of inflammatory skin lesions was 96.67%, and there was no significant difference between the two groups (P>0.05). The total effective rate of the treatment group in the treatment of non-inflammatory skin lesions was 86.67% and 76.67% in the control group, with no statistical significance between the two groups (P>0.05). The DLQI scores of both groups decreased significantly after treatment (P<0.05). The TCM syndrome score in the treatment group was lower than that in the control group after treatment (P<0.05). The levels of peripheral blood inflammatory cytokines in both groups were lower than those before treatment (P<0.05).
Compound Yinqiaojiedu mixture combined with acupuncture clearance is effective in the treatment of moderate acne heat-toxin syndrome with little adverse reaction, and it can improve the clinical syndrome of patients, which is worthy of clinical promotion and application.
To explore the effect of Shengji Huayu recipe combined with hemorrhoid fistula lotion on postoperative wound healing and the expression of B-cell lymphoma (Bcl)-2 protein and Bcl-2 associated X protein (Bax) in wound granulation tissue after complicated anal fistula surgery.
A total of 80 patients with complex anal fistulas treated at our hospital were selected and randomly divided into the control group and the experimental group according to the random number table method, with 40 cases in each group. The control group received routine treatment with anal fistula cleansing solution, while the experimental group received Shengji Huayu recipe on the basis of the control group. The therapeutic effects were compared between the two groups.
The total effective rate and wound healing rate of the experimental group were higher than those of the control group, and the scar area of the wound was smaller than that of the control group (P<0.05). After treatment, the symptom scores of pruritus, edema, exudation and pain in the two groups were mainly 1 point, and the score distribution in the experimental group was lower than that of the control group (P<0.05). After treatment, the levels of Actinobacteria, Proteobacteria and Bax in the experimental group were lower than those of the control group, and the levels of Bacteroides, Firmicutes and Bcl-2 were higher than those of the control group (P<0.05). No adverse reactions occurred in the two groups during treatment. During the follow-up of 6 months after discharge, the recurrence rate of the experimental group was lower than that of the control group (χ2=4.507, P=0.034).
Shengji Huayu recipe combined with Hemorrhoid Fistula Lotion has a significant effect in the application of elderly patients with complicated anal fistula surgery, which can effectively promote wound healing and symptom improvement, reduce wound scars and body inflammation, regulate the distribution of flora, and inhibit wound cell apoptosis. And it has high safety.
To investigate the efficacy of sintilimab combined with sorafenib in the treatment of advanced liver cancer and its influence on serum alpha fetoprotein (AFP) and protein induced by vitamin K absence or antagonist Ⅱ (PIVKA-Ⅱ).
A total of 88 patients with advanced liver cancer treated in our hospital from April 2019 to June 2020 were selected and divided into control group and combined group according to random number table method. The control group given conventional treatment combined with sorafenib, and the combined group was given sintilimab on the basis of the control group, with 44 cases in each group. The disease control rates, liver function index, AFP and PIVKA-Ⅱlevels were compared between the two groups. The adverse reactions of patients and the median survival situation were observed.
After treatment, the disease control rate of the combined group was higher than that of the control group (90.91% vs 72.73%, χ2=4.889, P=0.027). The levels of alanine aminotransferase, total bilirubin, AFP and PIVKA-Ⅱin both groups were lower than before treatment, and albumin was higher than before treatment, and the combined group was better than the control group, and the difference was statistically significant (P<0.05). The median survival time of the combined group was longer than that of the control group, and the difference was statistically significant (t=8.095, P<0.001). The 2-year survival rate in the combined group (17/44, 38.64%) was higher than that in the control group (8/44, 18.18%, χ2=5.320, P=0.021).
Sintilimab combined with sorafenib has good efficacy in the treatment of advanced liver cancer, can effectively improve the liver function of patients, and has a certain safety, worthy of clinical promotion and application.
Interleukin (IL)-4 is a multipotent cytokine that specifically binds to IL-4 receptor (IL-4R) on the cell surface to exert its biological effects. The expression level of IL-4R on the cell surface is relatively low under normal conditions and increases after being stimulated by hormones, stress and inflammation. At present, it has been found that IL-4/IL-4R plays an important role in the occurrence and development of atopic dermatitis, asthma, malignant tumor and other diseases. Currently, monoclonal antibody drugs targeting IL-4Rα have been used for clinical treatment, particularly for type 2 inflammation, and more than 8 therapeutic agents are in clinical research phase. This article reviewed the IL-4/IL-4R signaling pathway and related diseases, and the current status of research on therapeutic monoclonal antibody drugs targeting IL-4R and their clinical applications.
Glaucoma is a group of neurodegenerative diseases with pathological increase of intraocular pressure (IOP) as the main risk factor. Local use of IOP-lowering drugs is still the first line of treatment. Most of the aqueous humor flows out through the trabecular meshwork (TM) pathway, which is the main site of primary open-angle glaucoma. Therefore, novel IOP lowering drugs targeting the TM pathway are very important for the treatment of glaucoma. This article reviewed the mechanism and progress of Rho kinase inhibitors, nitric oxide donors and other novel IOP lowering drugs in recent years, aiming to provide clinical reference.
Retinal angiomatous proliferation (RAP) is a type of eye disease caused by angiogenesis. Microhemangioma is formed due to the imbalance of vascular growth factors and vascular inhibitory factors, which can seriously affect the visual acuity of patients. High expression of vascular endothelial growth factor (VEGF) can accelerate the development of RAP, and anti-VEGF can accelerate tumor atrophy and improve clinical efficacy. Currently, known anti-VEGF drugs include ranibizumab, bevacizumab and aflibercept, etc. In recent years, the role of anti-VEGF in RAP therapy has attracted much attention. This article reviewed the mechanism of VEGF in RAP and the progress of anti-VEGF therapy, aiming to provide clinical reference.
Psoriasis is a common chronic, recurrent and inflammatory disease in dermatology, and the exact etiology of psoriasis has not been completely understood. Genetic and environmental factors are important factors that induce or aggravate psoriasis, among which tobacco smoking and alcohol drinking are common controllable risk factors. Studies have shown that the tobacco smoking rate of psoriasis patients is higher than that of general population. Tobacco smoking may affect the occurrence and the progress of psoriasis by enhancing the expression of psoriasis-related genes and activating psoriasis-related signaling pathways, thus increasing the risk of psoriasis and leading to the exacerbation of the condition of psoriasis patients. However, whether tobacco smoking affects the treatment effect of psoriasis patients remains controversial, and more clinical studies are needed to confirm the impact of tobacco smoking and cessation on the treatment effect of psoriasis patients. Epidemiological investigation shows that the alcohol drinking rate of psoriasis patients is higher than that of general population. Existing research evidence suggests that alcohol drinking may have adverse effects on the occurrence and the progress of psoriasis by affecting psoriasis-related susceptibility genes, affecting the proliferation and differentiation of keratinocytes and inducing abnormal activation of immune cells. At the same time, alcohol drinking may weaken the therapeutic response of psoriasis, making the treatment less effective. However, there is no unified conclusion on the relationship between alcohol drinking and the occurrence and severity of psoriasis. So more studies are needed to explore the association between alcohol drinking and psoriasis.
Chronic obstructive pulmonary disease is a heterogeneous lung condition with multiple complications and requires multidimensional evaluation. The international classification of functioning, disability and health (ICF) constructs a bio-psycho-social model, including physical functions, body structure, activities and participation and environmental factors. Based on the ICF framework, this paper mainly applied the literature research method to analyze the core set of obstructive pulmonary disease (OPD), which means “why this category can be included in the ICF-OPD core sets”, and analyzed the clinical application of this set.